IS THERE AN ISLET STIMULATING PACEMAKER IN NORMAL AND DIABETIC MAN by Lang, D, Matthews, D, Burnett, M

ASSESSMENT OF INSULIN AND C-PEPTIDE HALF-LIFE IN MAN BY SOMATOSTATIN SUPPRESSION AND DEMONSTRATION THAT INSULIN DELIVERY IN THE BASAL STATE IS AN ON-OFF PHENOMENON by Matthews, D, Burnett, M, Turner, R

Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetes. by Hosker, J, Burnett, M, Matthews, DR, Turner, R

LACK OF BENEFIT FROM ACUTE ELEVATION OF PLASMA GLIBENCLAMIDE LEVELS BEFORE MEALS by Turner, R, Steemson, J, Burnett, M, Holman, R

Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. by Lang, D, Matthews, DR, Burnett, M, Turner, R

Control of pulsatile insulin secretion in man. by Matthews, DR, Lang, D, Burnett, M, Turner, R

Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetes. by Hosker, J, Burnett, M, Matthews, DR, Turner, R

Pulsatile, synchronous basal insulin and glucagon secretion in man. by Lang, D, Matthews, DR, Burnett, M, Ward, G, Turner, R

The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates. by Rudenski, A, Hosker, J, Burnett, M, Matthews, DR, Turner, R

Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. by Hosker, J, Rudenski, A, Burnett, M, Matthews, DR, Turner, R

ASSESSMENT OF B-CELL FUNCTION AND INSULIN RESISTANCE IN TYPE-II DIABETES BY CONTINUOUS INFUSION OF GLUCOSE WITH MODEL ASSESSMENT (CIGMA) by Turner, R, Hosker, J, Matthews, D, Rudenski, A, Burnett, M

The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppression. by Matthews, DR, Rudenski, A, Burnett, M, Darling, P, Turner, R

SOMATOSTATIN AS A POSSIBLE MEDIATOR OF INSULIN AND GLUCAGON PULSATILE SECRETION by Frank, M, Matthews, D, Spivey, R, Burnett, M, Turner, R

CONTINUOUS INFUSION OF GLUCOSE FOR 53 HOURS IN NORMAL MAN DOES NOT IMPAIR B-CELL FUNCTION, BUT INCREASES INSULIN RESISTANCE by Flax, H, Matthews, D, Levy, J, Coppack, S, Burnett, M, Turner, R

Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects. by Levy, J, Rudenski, A, Burnett, M, Knight, R, Matthews, DR, Turner, R

Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects. by Clark, P, Levy, J, Cox, L, Burnett, M, Turner, R, Hales, C

LOSS OF NORMAL SIGMOID, BETA-CELL DOSE-RESPONSE CURVE TO GLUCOSE IN NON-INSULIN-DEPENDENT DIABETES by Hosker, J, Burnett, M, Davies, E, Matthews, D, Rudenski, A, Turner, R

SIMPLE ASSESSMENT OF B-CELL FUNCTION IN NORMAL AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC SUBJECTS by Turner, R, Levy, J, Burnett, M, Knight, R, Matthews, D, Rudenski, A

The glucose stimulus-response curve of the beta-cell in physically trained humans, assessed by hyperglycemic clamps. by O'Rahilly, S, Hosker, J, Rudenski, A, Matthews, DR, Burnett, M, Turner, R

CONSTANT INFUSION OF GLUCOSE WITH MODEL ASSESSMENT AS A MEASURE OF INSULIN RESISTANCE IN MAN by Hosker, J, Matthews, D, Treacher, D, Burnett, M, Bown, E, Smith, A, Turner, R